questionText: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of establishing a British supplier of Creon.
answerText: The Department has been working with suppliers to address current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers, including pancreatic...
heading: Pancreatic Enzyme Replacement Therapy